Correlates of Adherence to Antiretroviral Therapy in HIV-Infected Children in Lomé, Togo, West Africa

Polisset, Julie; Ametonou, Francine; Arrive, Elise; Aho, Anthony; Perez, Freddy
February 2009
AIDS & Behavior;Feb2009, Vol. 13 Issue 1, p23
Academic Journal
We assessed pediatric adherence to antiretroviral therapy (ART) and examined associated factors among children in Togo, West Africa. Structured interviews of caregivers of consecutively enrolled HIV-infected children receiving ART in three HIV/AIDS care centers in Lome, Togo were conducted. Child perfect adherence reflected caregivers’ report of no antiretroviral drug doses missed neither in the past 4 days nor in the month before the interview. A total of 74 ART-treated children were included (median age 6 years). Of these, 42% of caregivers declared perfect adherence. In univariate analyses, the major factors relating to child non-adherence were: being female, living in an individual setting (vs. compound with enlarged family), receiving other ART than an NNRT-based regimen, drug regimens with six pills/spoons or more per day, caregiver other than biological parent, caregiver not declaring HIV-status, not participating to support groups and having perceived difficulty of antiretroviral (ARV) administration. In multivariate analysis, female gender, living in an individual setting, receiving other than NNRTI-based regimen and caregivers’ perceived difficulty of ARV administration remained independently associated with the reported child’s non-adherence. These data show low rates of perfect adherence to ART in children in West Africa, influenced by child and caregiver characteristics and suggest a need for counseling and education interventions as well as continuous psychological and social support.


Related Articles

  • Indinavir/Low-dose Ritonavir Containing HAART in HIV-1 Infected Children has Potent Antiretroviral Activity, but is Associated with Side Effects and Frequent Discontinuation of Treatment. Fraaij, P. L. A.; Verweel, G.; van Rossum, A. M. C.; Hartwig, N. G.; Burger, D. M.; de Groot, R. // Infection;Jun2007, Vol. 35 Issue 3, p186 

    We here present the study results of 21 HIV-1 infected children who were treated with indinavir plus low-dose ritonavir and two nucleoside reverse transcriptase inhibitors (NRTIs) for 48 weeks. Although this q12h HAART regimen had potent antiretroviral activity, it was frequently associated with...

  • HIV treatment prevents transmission of HIV.  // Africa Health;May2011, Vol. 33 Issue 4, p11 

    The article discusses the report from the US National Institutes of Health which found that an effective antiretroviral therapy regimen for HIV-positive person could prevent the risk of transmitting the virus to their uninfected sexual partner.

  • Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children. Resino, Salvador; Larrú, Beatriz; Bellón, Jose Ma; Resino, Rosa; de José, Isabel; Navarro, Marisa; Léon, Juan Antonio; Ramos, José Tomás; Mellado, Ma.José; Muñoz-Fernández, Ma Ángeles // BMC Infectious Diseases;2006, Vol. 6 Issue 1, p107 

    Background: Antiretroviral treatment (ART) in children has special features and consequently, results obtained from clinical trials with antiretroviral drugs in adults may not be representative of children. Nelfinavir (NFV) is an HIV-1 Protease Inhibitor (PI) which has become as one of the first...

  • Emerging Trends of HIV Drug Resistance in Chinese HIV-Infected Patients Receiving First-Line Highly Active Antiretroviral Therapy: A Systematic Review and Meta-Analysis. Liu, Huixin; Ma, Ye; Su, Yingying; Smith, M. Kumi; Liu, Ying; Jin, Yantao; Gu, Hongqiu; Wu, Jing; Zhu, Lin; Wang, Ning // Clinical Infectious Diseases;Nov2014, Vol. 59 Issue 10, p1495 

    Our study finds a rising trend of human immunodeficiency virus (HIV) drug resistance prevalence over longer durations of highly active antiretroviral therapy. China might face the danger of a new HIV epidemic generated by transmitted drug resistance.Background. Highly active antiretroviral...

  • Early Use of Antiretrovirals May Reduce HIV Transmission. Norman, Kayda // Applied Clinical Trials;Jun2011, Vol. 20 Issue 6, p17 

    The article discusses the findings of a study on a clinical trial known as the HPTN 052 in relation to the early use of oral antiretroviral therapy (ART). It states that the early use of ART may reduce the likelihood that a person with human immunodeficiency virus (HIV) will pass the virus to...

  • Vaccination in HIV-Infected Adults. Crum-Cianflone, Nancy F.; Wallace, Mark R. // AIDS Patient Care & STDs;Aug2014, Vol. 28 Issue 8, p397 

    Vaccines are critical components for protecting HIV-infected adults from an increasing number of preventable diseases. However, missed opportunities for vaccination among HIV-infected persons persist, likely due to concerns regarding the safety and efficacy of vaccines, as well as the changing...

  • Response to HAART in Treatment-Naive HIV-Infected Patients with a Prior Diagnosis of Tuberculosis or other Opportunistic Infections. Dronda, Fernando; Sobrino-Vegas, Paz; Hernández-Novoa, Beatriz; Caro-Murillo, Ana M.; Montero, Marta; Iribarren, José A.; Sanz, Jesús; Alonso, María del Mar; Labarga, Pablo; Bernal, Enrique; Moreno, Santiago // Current HIV Research;Jun2011, Vol. 9 Issue 4, p229 

    We aimed to evaluate immunological, virological and clinical response to HAART, as well as all-cause mortality, in treatment-naive patients with a diagnosis of tuberculosis (TB) in the prior 6 months, compared to subjects with another AIDS-defining illness (ADI) or event-free individuals in an...

  • Current use of antiretroviral treatment. A. C. Bailey; M. Fisher // British Medical Bulletin;Sep2008, Vol. 87 Issue 1, p175 

    : Introduction Antiretroviral therapy for HIV infection has transformed it from a terminal illness to a chronic manageable condition. This review summarizes the history of the treatment and explains the current practice in the field, including uses in prevention strategies. : Sources of data...

  • Predictors of Visceral Leishmaniasis Relapse in HIV-Infected Patients: A Systematic Review. Cota, Gláucia F.; Sousa, Marcos R. de; Rabello, Ana // PLoS Neglected Tropical Diseases;Jun2011, Vol. 5 Issue 6, p1 

    Background and Objectives: Visceral leishmaniasis (VL) is a common complication in AIDS patients living in Leishmaniaendemic areas. Although antiretroviral therapy has changed the clinical course of HIV infection and its associated illnesses, the prevention of VL relapses remains a challenge for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics